News Headlines Article

Stanford spinout Oculeve raises $16.6 million in pursuit of dry-eye treatment
San Francisco Business Times

A Stanford University medical device spinout aimed at treating dry-eye condition scored more than $16.6 million in funding, according to a Securities and Exchange Commission filing. Oculeve Inc., led by former Stanford vision research fellow D. Michael Ackermann, received the money from eight funders. It received $7.6 million in Series A funding in October 2012 from Kleiner Perkins Caufield & Byers, Versant Ventures and New Enterprise Associates.